NEUROPACE, INC. Increase (Decrease) in Accounts Receivable
NEUROPACE, INC. (NPCE) reported Increase (Decrease) in Accounts Receivable of $249.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-11
- NEUROPACE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $141.00K.
- NEUROPACE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $108.00K, a 95.82% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$257.00K, a 119.94% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.38M, a 334.91% increase year-over-year.
- NEUROPACE, INC. increase (decrease) in accounts receivable for fiscal 2025 was $1.83M, a 241.42% increase from fiscal 2024.
- NEUROPACE, INC. increase (decrease) in accounts receivable for fiscal 2024 was $536.00K, a 88.95% decline from fiscal 2023.
- NEUROPACE, INC. increase (decrease) in accounts receivable for fiscal 2023 was $4.85M, a 1140.41% increase from fiscal 2022.
- NEUROPACE, INC. increase (decrease) in accounts receivable for fiscal 2022 was $391.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $249.00K 10-Q · filed 2026-08-11 | -$8.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.38M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $108.00K 10-Q · filed 2026-05-12 | -$149.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.23M derived: sum of 3 quarters · filed 2026-05-12 | -$647.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | -$257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.13M derived: sum of 2 quarters · filed 2026-03-03 | -$755.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.83M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$498.00K derived: sum of 2 quarters · filed 2026-08-11 | $2.09M 10-Q · filed 2025-11-04 | $3.38M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $704.00K 10-Q · filed 2026-08-11 | $1.99M derived: sum of 3 quarters · filed 2026-08-11 | $2.31M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $2.58M 10-Q · filed 2026-05-12 | $3.87M derived: sum of 2 quarters · filed 2026-05-12 | $4.19M derived: sum of 3 quarters · filed 2026-05-12 | $3.80M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.61M derived: sum of 2 quarters · filed 2026-03-03 | $1.22M derived: sum of 3 quarters · filed 2026-03-03 | $536.00K 10-K · filed 2026-03-03 | $537.00K 10-K · filed 2025-03-04 |
| 2024-09-30 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$71.00K derived: sum of 2 quarters · filed 2025-11-04 | -$753.00K 10-Q · filed 2025-11-04 | $299.00K derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | -$389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.07M 10-Q · filed 2025-08-12 | -$19.00K derived: sum of 3 quarters · filed 2025-08-12 | $384.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$682.00K 10-Q · filed 2025-05-13 | $370.00K derived: sum of 2 quarters · filed 2025-05-13 | $773.00K derived: sum of 3 quarters · filed 2025-05-13 | $2.46M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.46M derived: sum of 2 quarters · filed 2025-03-04 | $3.14M derived: sum of 3 quarters · filed 2025-03-04 | $4.85M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.08M derived: sum of 2 quarters · filed 2024-11-12 | $3.80M 10-Q · filed 2024-11-12 | $3.41M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $3.40M 10-Q · filed 2024-08-13 | $3.00M derived: sum of 3 quarters · filed 2024-08-13 | $2.40M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $1.71M 10-Q · filed 2024-05-08 | $1.32M derived: sum of 2 quarters · filed 2024-05-08 | $720.00K derived: sum of 3 quarters · filed 2024-05-08 | $134.00K derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | -$392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$993.00K derived: sum of 2 quarters · filed 2024-03-05 | -$1.58M derived: sum of 3 quarters · filed 2024-03-05 | $391.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | -$601.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.19M derived: sum of 2 quarters · filed 2023-11-06 | $783.00K 10-Q · filed 2023-11-06 | $1.26M derived: sum of 4 quarters · filed 2023-11-06 | |
| 2022-06-30 | -$586.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.38M 10-Q · filed 2023-08-08 | $1.86M derived: sum of 3 quarters · filed 2023-08-08 | $770.00K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $1.97M 10-Q · filed 2023-05-04 | $2.45M derived: sum of 2 quarters · filed 2023-05-04 | $1.36M derived: sum of 3 quarters · filed 2023-05-04 | $860.00K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$614.00K derived: sum of 2 quarters · filed 2023-03-02 | -$1.11M derived: sum of 3 quarters · filed 2023-03-02 | -$1.30M 10-K · filed 2023-03-02 | |
| 2021-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.59M derived: sum of 2 quarters · filed 2022-11-08 | -$1.78M 10-Q · filed 2022-11-08 | -$1.44M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | -$496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$690.00K 10-Q · filed 2022-08-11 | -$350.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.66M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$194.00K 10-Q · filed 2022-05-12 | $146.00K derived: sum of 2 quarters · filed 2022-05-12 | $2.15M derived: sum of 3 quarters · filed 2022-05-12 | $1.99M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.35M derived: sum of 2 quarters · filed 2022-03-10 | $2.18M derived: sum of 3 quarters · filed 2022-03-10 | $2.38M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.84M derived: sum of 2 quarters · filed 2021-11-10 | $2.04M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $32.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $197.00K 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |